Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Cognitive Models That Predict Physician Judgments of Capacity to Consent in Mild Alzheimer's Disease

View through CrossRef
OBJECTIVE: To identify cognitive measures that predict consent capacity of normal and demented older adults as judged by experienced physicians. This study is a companion to the physician competency judgment research reported in this issue. DESIGN: Predictor models for competency judgments of individual physicians were developed using independent patient neuropsychological test measures and discriminant function analyses (DFA). SETTING: University medical center. PARTICIPANTS: Subjects were 16 normal older controls and 29 patients with mild AD (MMSE ≥ 20). Five experienced medical center physicians were recruited as competency decision‐makers. MEASUREMENTS: Subjects were videotaped responding to a standardized consent capacity interview (SCCI) designed to evaluate capacity to consent to treatment. Interview subjects were also independently administered (off videotape) a battery of neuropsychological measures theoretically and empirically linked to competency function. Study physicians blinded to subject diagnosis and neuropsychological test performance individually viewed each SCCI videotape and made a judgment of competent or incompetent to consent to treatment. Stepwise DFA identified neuropsychological predictors of each physician's competency judgments for the full sample (N = 45). Classification DFAs determined how accurately these predictor models classified competency outcomes assigned by the individual physician. RESULTS: Cognitive models differed across individual physicians and were related to stringency of judgments for AD patients. Under stepwise DFA, delayed verbal recall ( R 2 = .57, P < .0001) predicted judgments of Physician 1 (incompetency rate of 90% for AD patients), short term verbal recall ( R 2 = .43, P < .0001) predicted judgments of Physician 2 (incompetency rate of 52%), phonemic word fluency ( R 2 = .27, P < .001) predicted judgments of Physician 3 (incompetency rate of 24%), and visuomotor tracking/sequencing ( R 2 = .31, P < .001) predicted judgments of Physician 4 (incompetency rate of 14%). (No predictor model was available for Physician 5 as this physician found all subjects to be competent). These single predictor solutions correctly classified 93%, 87%, 87%, and 96% of cases for Physicians 1–4, respectively. Use of two predictor solutions achieved successful classification rates between 98% and 100%. CONCLUSIONS: We identified two cognitive models of consent capacity as judged by physicians: (1) verbal recall and (2) simple executive function. The verbal recall model predicted judgments of physicians likely to find mild AD patients incompetent, whereas the executive function model predicted judgments of physicians likely to find mild AD patients competent. Assessment of verbal recall and simple executive functions may provide important information in the clinical evaluation of capacity to consent to treatment.
Title: Cognitive Models That Predict Physician Judgments of Capacity to Consent in Mild Alzheimer's Disease
Description:
OBJECTIVE: To identify cognitive measures that predict consent capacity of normal and demented older adults as judged by experienced physicians.
This study is a companion to the physician competency judgment research reported in this issue.
DESIGN: Predictor models for competency judgments of individual physicians were developed using independent patient neuropsychological test measures and discriminant function analyses (DFA).
SETTING: University medical center.
PARTICIPANTS: Subjects were 16 normal older controls and 29 patients with mild AD (MMSE ≥ 20).
Five experienced medical center physicians were recruited as competency decision‐makers.
MEASUREMENTS: Subjects were videotaped responding to a standardized consent capacity interview (SCCI) designed to evaluate capacity to consent to treatment.
Interview subjects were also independently administered (off videotape) a battery of neuropsychological measures theoretically and empirically linked to competency function.
Study physicians blinded to subject diagnosis and neuropsychological test performance individually viewed each SCCI videotape and made a judgment of competent or incompetent to consent to treatment.
Stepwise DFA identified neuropsychological predictors of each physician's competency judgments for the full sample (N = 45).
Classification DFAs determined how accurately these predictor models classified competency outcomes assigned by the individual physician.
RESULTS: Cognitive models differed across individual physicians and were related to stringency of judgments for AD patients.
Under stepwise DFA, delayed verbal recall ( R 2 = .
57, P < .
0001) predicted judgments of Physician 1 (incompetency rate of 90% for AD patients), short term verbal recall ( R 2 = .
43, P < .
0001) predicted judgments of Physician 2 (incompetency rate of 52%), phonemic word fluency ( R 2 = .
27, P < .
001) predicted judgments of Physician 3 (incompetency rate of 24%), and visuomotor tracking/sequencing ( R 2 = .
31, P < .
001) predicted judgments of Physician 4 (incompetency rate of 14%).
(No predictor model was available for Physician 5 as this physician found all subjects to be competent).
These single predictor solutions correctly classified 93%, 87%, 87%, and 96% of cases for Physicians 1–4, respectively.
Use of two predictor solutions achieved successful classification rates between 98% and 100%.
CONCLUSIONS: We identified two cognitive models of consent capacity as judged by physicians: (1) verbal recall and (2) simple executive function.
The verbal recall model predicted judgments of physicians likely to find mild AD patients incompetent, whereas the executive function model predicted judgments of physicians likely to find mild AD patients competent.
Assessment of verbal recall and simple executive functions may provide important information in the clinical evaluation of capacity to consent to treatment.

Related Results

Consistency of Physician Judgments of Capacity to Consent in Mild Alzheimer's Disease
Consistency of Physician Judgments of Capacity to Consent in Mild Alzheimer's Disease
OBJECTIVE: To investigate the agreement of physician judgments of capacity to consent to treatment for normal and demented older adults. ...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Abstract— Alzheimer's disease is a neurodegenerative disease that develops gradually, and is associated with cardiovascular and cerebrovascular problems. Alzheimer's is a serious d...
Social Media Use in Neurology: An Analysis of Alzheimer's Information on TikTok with Emphasis on Role of Healthcare Professionals
Social Media Use in Neurology: An Analysis of Alzheimer's Information on TikTok with Emphasis on Role of Healthcare Professionals
Abstract Introduction Alzheimer's disease (AD) is the most common neurodegenerative cause of dementia. Social media has become a major source of information for patients and famili...
Leveraging speech and artificial intelligence to screen for early Alzheimer’s disease and amyloid beta positivity
Leveraging speech and artificial intelligence to screen for early Alzheimer’s disease and amyloid beta positivity
Abstract Early detection of Alzheimer’s disease is required to identify patients suitable for disease-modifying medications and to improve access to non-pharmacologi...
Race, polygenic risk and their association with incident dementia among older US adults
Race, polygenic risk and their association with incident dementia among older US adults
AbstractDementia incidence increases steadily with age at rates that may vary across racial groups. This racial disparity may be attributable to polygenic risk, as well as lifestyl...
A randomized control trial of re-designed and shorter research informed consent forms to improve comprehension
A randomized control trial of re-designed and shorter research informed consent forms to improve comprehension
Background/Aims: Informed consent forms are an essential component of ethical clinical research. However, they are failing. They are long, legalistic, and writt...
Clinical characteristics and biomarker profile in early- and late-onset Alzheimer’s disease: the Shanghai Memory Study
Clinical characteristics and biomarker profile in early- and late-onset Alzheimer’s disease: the Shanghai Memory Study
Abstract Early-onset Alzheimer’s disease constitutes ∼5–10% of Alzheimer’s disease. Its clinical characteristics and biomarker profiles are not well documented. To c...

Back to Top